Support your at-risk "rising risk" patients

Our platform makes it easy to help your patients sustain their health journey through automatic intervention programs. From nutrition education and blood-pressure monitoring you can empower real behavior change in your at-risk patients. 

Healthy weight program: 

Support your patients who have elevated BMIs through our platform’s built-in educational programming. Offer in-depth nutrition, disease prevention, and behavior change strategies through ongoing monitoring to help your patients get healthier. Normalize key biometrics as weight, blood pressure and blood sugar ages 12 to 74

"PreventScripts is an AI-powered care model transforming chronic disease prevention in rural primary care by equipping providers with predictive analytics, behavioral science, and remote monitoring to engage at-risk patients before costly conditions develop. Patients using PreventScripts see clinically significant outcomes, including an average A1c reduction of 1.45%, sustained blood pressure improvements, and 82% achieving weight stability or loss. With over 36,000 patients under contract PreventScripts creates new revenue streams while improving patient outcomes and lowering costs by 1058$ PMPY in a 4:1 Return on Investment.

Company: https://www.preventscripts.com/company

Software Platform Demo: https://app.puppydog.io/play/vug7lo

• eCART is a research-based, AI-driven software as a medical device (SaMD) that utilizes a machine learning algorithm to continuously assess hospitalized patients’ risk of impending death or intensive care unit (ICU) transfer, assisting medical staff in swift and accurate recognition of patients requiring increased medical attention. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts likelihood of critical illness onset, hours before it happens.
• eCART received FDA 510(k) clearance in 2024, with clinical performance data of nearly two million hospitalizations from 21 hospitals, including an unprecedented level of real-world prospective data, to ensure consistent accuracy across geography, age, race, and top medical conditions (e.g. sepsis, COPD, heart failure). 
• Built upon more than a decade of ongoing scientific research, eCART was developed at UChicago Medicine by Dr. Dana Edelson, MD, MS and Dr. Matthew Churpek, MD, PhD and is well chronicled in published literature. The analytic and workflow have been in use in clinical practice since 2016.

At AgileMD, we are building the most advanced real-time predictive analytics and clinical pathways platform for hospitals.

To date, AgileMD tools have been used on more than 4 million patient encounters by more than 135,000 clinical users in over 250 hospitals, including some of the nation's leading academic medical centers. AgileMD's eCART clinical deterioration prediction software is FDA cleared and the first AI-powered early warning device for ward patients to go through the FDA process with real-world prospective data. 

AgileMD is backed by premier start-up partners MATTER, YCombinator, and Rock Health, and our cutting-edge analytics are built on more than decade of ongoing research at the University of Chicago. In 2021, AgileMD garnered nearly $3 million in combined federal research and development funding from the U.S. Department of Health and Human Services (HHS), including the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA).

PreventScripts is positioned to be the leader in prevention-focused, evidence-based, point-of-care solutions for primary care.”

The market is fragmented: on one side, we have thousands of mobile health apps targeting consumers, but they lack clinical integration. On the other, we have revenue cycle and RPM companies helping providers financially, but they don’t focus on proactive prevention.”

We sit at the intersection of both—offering clinically integrated, prevention-focused solutions that improve patient outcomes while driving revenue for providers. 

PreventScripts is positioned to be the leader in prevention-focused, evidence-based, point-of-care solutions for primary care.

The market is fragmented: on one side, we have thousands of mobile health apps targeting consumers, but they lack clinical integration. On the other, we have revenue cycle and RPM companies helping providers financially, but they don’t focus on proactive prevention.

We sit at the intersection of both—offering clinically integrated, prevention-focused solutions that improve patient outcomes while driving revenue for providers. 

• Continuously monitors EHR data in real time
• Stratifies hospitalized patients by risk of impending all-cause clinical deterioration and sepsis
• Notifies inpatient providers when patient may need additional assessment and management
• Recommends clinical pathways with integrated order entry

• Authorized: FDA 510(k) cleared
• Tested: Derived and validated in nearly 3 million patient encounters across 28 hospitals
• Experienced: 8+ years in clinical use; 10+ years of published academic literature on value over other early warning scores
• Accurate: High sensitiviy and specificity, meaning fewer false alarms and more efficient focus on the highest risk patients
• Integrated: Embedded cross-team workflow ensures that risk scores are not ignored and action is taken
• Benchmarked: Robust reporting, benchmarking, and implementation support drive quality improvement